Serial #79368658
LIVE

Serial Number

79368658

Owner

Cytogen, Inc.

Attorney

Patricia A Wilczynski Brozek

Filing Date

Dec 13, 2022

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79368658 Trademark

Serial Number: 79368658 • Registration: 7324629

Serial #79368658 is a trademark filed by Cytogen, Inc. on December 13, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Cytogen, Inc. (3 trademarks)

A-8F, MunjeongSK V1 GLMetrocity, 128, Beobwon-ro,

Entity Type: 03

Trademark Details

Filing Date

December 13, 2022

Registration Date

March 12, 2024

Published for Opposition

December 26, 2023

Goods & Services

Diagnostic reagents for immunization against disease; diagnostic test reagents for veterinary purposes; diagnostic agents for pharmaceutical use; biological and chemical reagents for medical or veterinary purposes; diagnostic test reagents for medical or veterinary purposes; biological preparations for medical or veterinary purposes, for treatment of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; biochemical preparations for medical or veterinary purposes, for treatment of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; biological reagents for medical purposes; biological preparations for medical purposes, for treatment of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; diagnostic chemical reagents for medical use; chemical preparations for testing blood for medical purposes; reagents for blood grouping for medical purposes; reactants for medical diagnosis; clinical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes; antibodies for medical purposes; blood components for medical purposes; pharmaceutical preparations for use in hematology

Reagents for scientific or medical research use; biological preparations for scientific or laboratory purposes; diagnostic preparations for scientific or research use; diagnostic reagents for scientific use; diagnostic preparations for scientific use; antibodies for scientific purposes, other than for medical or veterinary use; antibody reagents for scientific purposes; chemical reagents for scientific purposes; biological preparations for use in biotechnology other than medical use; reagents for cell transformation other than for medical or veterinary use; reagents for research purposes; chemical reagents for use in genetic research; reagents for medical research; diagnostic reagents, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; reagents for chemical analyses; chemical reagents, other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis

Medical and healthcare services relating to DNA, genetics and genetic testing; health care; physical examination services; medical analysis services for cancer diagnosis and prognosis; providing information in the field of cancer prevention, screening, diagnosis and treatment; genetic testing for medical purposes; DNA analysis for medical purposes; DNA screening for medical purposes; medical testing for diagnostic or treatment purposes; medical laboratory services for the analysis of blood samples; medical laboratory services for the analysis of blood samples taken from patients

Home virus test kits comprised primarily of medical diagnostic apparatus for testing for viruses, test strips and reagents; medical measuring instruments for cancer diagnosis; apparatus for the diagnosis of inflammatory diseases; genetic testing apparatus for medical purposes; genetic verification apparatus for medical purposes; apparatus for DNA and RNA testing for medical purposes; immunofluorescence analysis apparatus for medical purposes; cell testing apparatus for medical purposes; medical genetic analyzer; apparatus for carrying-out diagnostic tests for medical purposes, namely, for diagnosis of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; medical diagnostic apparatus and instruments, namely, for diagnosis of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; diagnostic apparatus for medical purposes, namely, for diagnosis of cancer, infectious diseases, autoimmune disorders, genetic disorders and blood disorders; ultrasonic diagnostic instruments for medical use; medical blood heaters; blood analysis apparatus for diagnosis; blood warmers; blood testing apparatus; apparatus for blood analysis; blood filters

Genetic testing for scientific research purposes; DNA analysis for scientific research purposes; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of pharmacy; research in the field of gene analysis; scientific research in the field of genetics and genetic engineering; medical laboratories; scientific research in the field of biomedicine; analysis and evaluation of medical product development; blood testing for medical research; clinical research in the field of oncology, genetics, viral diseases, carcinoid tumors, pharmaceutical cancer treatment, lymphatic cancer, liquid biopsy, drug efficiency and drug resistance; blood analysis services; blood analysis services for scientific research purposes

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Feb 7, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 11, 2024 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 21, 2024 FICS
FINAL DISPOSITION PROCESSED
Jul 21, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 13, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 12, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Mar 12, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Jan 2, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 26, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 26, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 6, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 6, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 6, 2023 NONP
CORRECTION SENT TO IB
Nov 27, 2023 CRSN
CORRECTION CREATED FOR IB
Nov 27, 2023 CRCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 17, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 16, 2023 TROA
REFUSAL PROCESSED BY IB
Oct 25, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 2, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 2, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 20, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 19, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 18, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
May 9, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 4, 2023 REPR